Avalon GloboCare Corp Announces FDA Registration Renewal for KetoAir™
I'm PortAI, I can summarize articles.
Avalon GloboCare Corp has announced the FDA registration renewal for its KetoAir™ device, a breathalyzer designed for ketogenic health management. This renewal supports the company's ongoing presence in the U.S. market. A B2B and B2C launch is planned via the Catch-Up™ platform in Q2 2026, which aims to enhance marketing and digital engagement. The device provides real-time metabolic insights for users following a ketogenic diet.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments